ω,ω'-乙二硫二磺酸结构式
|
常用名 | ω,ω'-乙二硫二磺酸 | 英文名 | Coenzyme M |
---|---|---|---|---|
CAS号 | 45127-11-5 | 分子量 | 282.379 | |
密度 | 1.8±0.1 g/cm3 | 沸点 | N/A | |
分子式 | C4H10O6S4 | 熔点 | N/A | |
MSDS | N/A | 闪点 | N/A |
中文名 | 辅酶 M |
---|---|
英文名 | 2-(2-sulfoethyldisulfanyl)ethanesulfonic acid |
英文别名 | 更多 |
密度 | 1.8±0.1 g/cm3 |
---|---|
分子式 | C4H10O6S4 |
分子量 | 282.379 |
精确质量 | 281.936005 |
PSA | 176.10000 |
LogP | -1.83 |
折射率 | 1.637 |
海关编码 | 2930909090 |
---|
~97% ω,ω'-乙二硫二磺酸 45127-11-5 |
文献:Huang, Qiuli; Kochat, Harry; Chen, Xinghai Patent: US2006/63949 A1, 2006 ; Location in patent: Page/Page column 2 ; |
~% ω,ω'-乙二硫二磺酸 45127-11-5 |
文献:Danehy,J.P.; Hunter,W.E. Journal of Organic Chemistry, 1967 , vol. 32, # 7 p. 2047 - 2053 |
~% ω,ω'-乙二硫二磺酸 45127-11-5 |
文献:Fedoseyeva,V.N.; Petrun'kin,V.E. Sov. Prog. Chem. (Engl. Transl.), 1967 , vol. 33, # 6 p. 596 - 597,57 - 58 |
~% ω,ω'-乙二硫二磺酸 45127-11-5 |
文献:Lemaire,H.; Rieger,M. Journal of Organic Chemistry, 1961 , vol. 26, p. 1330 - 1331 |
ω,ω'-乙二硫二磺酸上游产品 3 | |
---|---|
ω,ω'-乙二硫二磺酸下游产品 0 |
海关编码 | 2930909090 |
---|---|
中文概述 | 2930909090. 其他有机硫化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:30.0% |
申报要素 | 品名, 成分含量, 用途 |
Summary | 2930909090. other organo-sulphur compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
Mechanistic study of BNP7787-mediated cisplatin nephroprotection: modulation of human aminopeptidase N.
Cancer Chemother. Pharmacol. 67(2) , 381-91, (2011) Previous studies from our laboratory have identified a role for gamma-glutamyl transpeptidase (GGT) in BNP7787 (disodium 2,2'-dithio-bis ethane sulfonate, dimesna, Tavocept™)-mediated cisplatin nephro... |
|
Phase II randomized study of dose-dense docetaxel and cisplatin every 2 weeks with pegfilgrastim and darbepoetin alfa with and without the chemoprotector BNP7787 in patients with advanced non-small cell lung cancer (CALGB 30303).
J. Thorac. Oncol. 3(10) , 1159-65, (2008) We investigated dose-dense docetaxel and cisplatin in patients with measurable non-small cell lung cancer in a randomized phase II study without [A] or with [B] a putative chemoprotective agent, BNP77... |
|
New approaches to drug discovery and development: a mechanism-based approach to pharmaceutical research and its application to BNP7787, a novel chemoprotective agent.
Cancer Chemother. Pharmacol. 52 Suppl 1 , S3-15, (2003) Any approach applied to drug discovery and development by the medical community and pharmaceutical industry has a direct impact on the future availability of improved, novel, and curative therapies fo... |
Ethanesulfonic acid, 2,2'-dithiobis- |
2,2'-Dithiodiethanesulfonic acid |
2,2'-dithiobisethanesulfonic acid |
Ethanesulfonic acid,2,2'-dithiobis |
2,2'-Disulfanediyldiethanesulfonic acid |
Coenzyme |